Related references
Note: Only part of the references are listed.trans-10,cis-12-Conjugated Linoleic Acid Instigates Inflammation in Human Adipocytes Compared with Preadipocytes
Kristina Martinez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Inflammation and insulin resistance induced by trans-10, cis-12 conjugated linoleic acid depend on intracellular calcium levels in primary cultures of human adipocytes
Arion Kennedy et al.
JOURNAL OF LIPID RESEARCH (2010)
Antiobesity mechanisms of action of conjugated linoleic acid
Arion Kennedy et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)
Knockdown of JNK rescues 3T3-L1 adipocytes from insulin resistance induced by mitochondrial dysfunction
Toni Kiln et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes Involvement of Nuclear Factor-kappa B and c-Jun NH2-Terminal Kinase Pathways
Ping Jiao et al.
DIABETES (2009)
The c-Jun N-Terminal Kinase Mediates the Induction of Oxidative Stress and Insulin Resistance by Palmitate and Toll-like Receptor 2 and 4 Ligands in 3T3-L1 Adipocytes
J. E. Davis et al.
HORMONE AND METABOLIC RESEARCH (2009)
Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol
Arion Kennedy et al.
JOURNAL OF LIPID RESEARCH (2009)
Silencing Jnk1 and Jnk2 accelerates basal lipolysis and promotes fatty acid re-esterification in mouse adipocytes
A. V. Rozo et al.
DIABETOLOGIA (2008)
Modulation of PPAR activity via phosphorylation
Katherine A. Burns et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue
Fiona Moloney et al.
DIABETES (2007)
Conjugated linoleic acid increases skeletal muscle ceramide content and decreases insulin sensitivity in overweight, non-diabetic humans
A. Brianne Thrush et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2007)
Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance
Gurol Tuncman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Nutiritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue
Helene Poirier et al.
DIABETES (2006)
Conjugated linoleic acid promotes human adipocyte insulin resistance through NFκB-dependent cytokine production
SK Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phosphorylation of PPARs: from molecular characterization to physiological relevance
C Diradourian et al.
BIOCHIMIE (2005)
Conjugated linoleic acid induces human adipocyte delipidation - Autocrine/paracrine regulation of MEK/ERK signaling by adipocytokines
JM Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN δ domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes
D Holzberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Troglitazone antagonizes tumor necrosis factor-α-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-κB
H Ruan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cytokines suppress adipogenesis and PPAR-function through the TAK1/TAB1/NIK cascade
M Suzawa et al.
NATURE CELL BIOLOGY (2003)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Treatment with dietary trans10cis12 conjugated linoleic add causes isomerm-specific insulin resistance in obese men with the metabolic syndrome
U Risérus et al.
DIABETES CARE (2002)
Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes -: Nuclear factor-κB activation by TNF-α is obligatory
H Ruan et al.
DIABETES (2002)
Interferon-γ-mediated activation and ubiquitin-proteasome-dependent degradation of PPARγ in adipocytes
ZE Floyd et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
BL Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)